The Tromsø Heart Study: serum selenium and risk of myocardial infarction a nested case-control study.
AUTOR(ES)
Ringstad, J
RESUMO
The association between serum selenium concentration and the risk of myocardial infarction was studied in a nested case-control study. Altogether 59 men, initially free of disease, aged 28-54 at the time of blood sampling, died suddenly or experienced a fatal or non-fatal myocardial infarction during a six year follow-up period. Case-control pairs came from a population of 9364 persons examined in 1979-80 in the second Tromsø Heart Study. No significant difference was observed between serum selenium in cases and controls (p = 0.34). The major determinants of myocardial infarction and sudden death were raised levels of serum cholesterol and triglycerides (p less than or equal to 0.001) and high systolic blood pressure (p less than 0.05). Thus, in this population with intermediate selenium intake, low serum selenium is not associated with an excess risk of myocardial infarction.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1052655Documentos Relacionados
- Oral contraceptive use and risk of myocardial infarction: an Italian case-control study.
- Risk factors for gonorrhoea: case-control study.
- Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: prospective nested case-control study
- Effect of beer drinking on risk of myocardial infarction: population based case-control study
- Oral contraceptives and myocardial infarction: results of the MICA case-control study